Clinical Trial Detail

NCT ID NCT02059213
Title A Phase II Study of Androgen Deprivation Therapy With or Without PD 0332991 in RB-Positive Metastatic Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Cancer Center
Indications

prostate cancer

Therapies

Goserelin

Palbociclib

Bicalutamide

Leuprolide

Age Groups: adult senior

Additional content available in CKB BOOST